MedTrace Logo

Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial Neoplasia

NCT03218436 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2024-07-23

No results posted yet for this study

Summary

Cervical intraepithelial neoplasia will be treated with physical low temperature plasma in the plasma cohort compared to watchful waiting in the control cohort.

Primary endpoint after 3-6 months: Pathological remission.

Secondary endpoint: HPV remission.

Conditions

  • Cervical Intraepithelial Neoplasia

Interventions

PROCEDURE

CAP treatment

Treatment with low-temperature argon plasma during colposcopic examination. No general anesthesia required.

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Melanie Henes, Dr. · Department for Women's Health

  • Martin Weiss, Dr. · Department for Women's Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03218436 on ClinicalTrials.gov